PUBLISHER: Polaris Market Research | PRODUCT CODE: 1338972

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1338972

Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032

PUBLISHED: June 23, 2023

PAGES: 117 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The infantile spasm therapeutics market size is expected to reach USD 181.85 million by 2032, according to a new study by Polaris Market Research. The report "Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market has witnessed some revolutionary drug developments including generic drugs, for e.g., MSN Labs launched India's first generic Vigabatrin (Viganext) that is to be administered as a powder. The recent technological advancements particularly in advance treatment and preventive treatment of Infantile Spasm Therapeutics, like development of non-invasive automated seizure detection device that help in early detection of seizure to provide better solutions for to treat the disorder. Due to presence of telemedicine and teleconsultation, during the times of COVID-19, Infantile Spasm Therapeutics market has seen a jump as it was widely used during the times of lockdown. This huge demand was seen due to the advantages of easy and comfortable check-up, consultation from across the globe amongst others.

The presence and increase of awareness campaigns like that of Infantile Spasm Therapeutics Awareness Week every first week of December across the globe contribute to positively impacting the market. Also, the growing demand for novel and compliant drugs is made possible by an increasing concentration on investments associated to research and development, which leads to an increase in new drug development. According to World Bank data, 2.63% of global GDP is invested in research and development of better alternatives to the drugs available in the market.

Infantile Spasm Therapeutics Market Report Highlights

The anticonvulsants segment accounted for the largest revenue share. This is due to its higher efficacy and ease of tolerance in patients undergoing treatment

Adrenocorticotropic hormone segment accounted to hold largest revenue share as it is preferred by the clinicians and prescribers to treat Infantile Spasm Therapeutics owing to its safety and efficacy making it the drug of choice

Liquid segment accounted for largest market share due to its advantages like ease of administration in infantile patients, high patient compliance, and rapid onset of action

Hospital Pharmacy segment account for a largest market share owing to the reason that Infantile Spasm Therapeutics requires treatment in presence of a medical practitioner and, hospital pharmacies provide convenience as compared to other modes of distribution

North America dominated the market as there is more early acceptance of techniques, better and more developed healthcare infrastructure and constant drive for product innovation.

The major players in the market include Lundbeck, Mallinckrodt Pharmaceuticals, Catalyst Pharmaceuticals, GW Pharmaceuticals, Retrophin, Valerion Therapeutics, Orphelia Pharma, Insys Therapeutics, & Anavex Life Sciences.

Polaris Market Research has segmented the Infantile Spasm Therapeutics market report based on therapeutic class, dosage, route of administration, distribution channel, drug type, and region:

Infantile Spasm Therapeutics Market, Therapeutic Class Outlook (Revenue - USD Million, 2019 - 2032)

Anticonvulsants
Corticosteroids
Others

Infantile Spasm Therapeutics Market, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

Vigabatrin
Adrenocorticotropic Hormone
Others (Phase III)

Infantile Spasm Therapeutics Market, Dosage Outlook (Revenue - USD Million, 2019 - 2032)

Solid
Liquid

Infantile Spasm Therapeutics Market, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Oral
Parenteral
Others

Infantile Spasm Therapeutics Market, Distribution Channel Outlook (Revenue - USD Million, 2019 -2032)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Infantile Spasm Therapeutics Market, Region Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Product Code: PM3416

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Infantile Spasm Therapeutics Market Insights

4.1. Infantile Spasm Therapeutics - Industry Snapshot
4.2. Infantile Spasm Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising incidence of infantile spasms in newborns
  - 4.2.1.2. Increasing government supports
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of treatment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Infantile Spasm Therapeutics Industry Trends
4.6. COVID-19 Impact Analysis

5. Global Infantile Spasm Therapeutics Market, by Therapeutic Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
5.3. Anticonvulsants
- 5.3.1. Global Infantile Spasm Therapeutics Market, by Anticonvulsants, by Region, 2019-2032 (USD Million)
5.4. Corticosteroids
- 5.4.1. Global Infantile Spasm Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Million)
5.5. Others
- 5.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Infantile Spasm Therapeutics Market, by Drug Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
6.3. Vigabatrin
- 6.3.1. Global Infantile Spasm Therapeutics Market, by Vigabatrin, by Region, 2019-2032 (USD Million)
6.4. Adrenocorticotropic Hormone
- 6.4.1. Global Infantile Spasm Therapeutics Market, by Adrenocorticotropic Hormone, by Region, 2019-2032 (USD Million)
6.5. Others (Phase III)
- 6.5.1. Global Infantile Spasm Therapeutics Market, by Others (Phase III), by Region, 2019-2032 (USD Million)

7. Global Infantile Spasm Therapeutics Market, by Dosage

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
7.3. Solid
- 7.3.1. Global Infantile Spasm Therapeutics Market, by Solid, by Region, 2019-2032 (USD Million)
7.4. Liquid
- 7.4.1. Global Infantile Spasm Therapeutics Market, by Liquid, by Region, 2019-2032 (USD Million)

8. Global Infantile Spasm Therapeutics Market, by Route of Administration

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
8.3. Oral
- 8.3.1. Global Infantile Spasm Therapeutics Market, by Oral, by Region, 2019-2032 (USD Million)
8.4. Parenteral
- 8.4.1. Global Infantile Spasm Therapeutics Market, by Parenteral, by Region, 2019-2032 (USD Million)
8.5. Others
- 8.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Infantile Spasm Therapeutics Market, by Distribution Channel

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
9.3. Hospital Pharmacy
- 9.3.1. Global Infantile Spasm Therapeutics Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)
9.4. Retail Pharmacy
- 9.4.1. Global Infantile Spasm Therapeutics Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
9.5. Online Pharmacy
- 9.5.1. Global Infantile Spasm Therapeutics Market, by Online Pharmacy, by Region, 2019-2032 (USD Million)

10. Global Infantile Spasm Therapeutics Market, by Geography

10.1. Key findings
10.2. Introduction
- 10.2.1. Infantile Spasm Therapeutics Market Assessment, By Geography, 2019-2032 (USD Million)
10.3. Infantile Spasm Therapeutics Market - North America
- 10.3.1. North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
- 10.3.2. North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
- 10.3.3. North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
- 10.3.4. North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
- 10.3.5. North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.3.6. Infantile Spasm Therapeutics Market - U.S.
  - 10.3.6.1. U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.3.6.2. U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.3.6.3. U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.3.6.4. U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.3.6.5. U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.3.7. Infantile Spasm Therapeutics Market - Canada
  - 10.3.7.1. Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.3.7.2. Canada.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.3.7.3. Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.3.7.4. Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.3.7.5. Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
10.4. Infantile Spasm Therapeutics Market - Europe
- 10.4.1. Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
- 10.4.2. Europe.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
- 10.4.3. Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
- 10.4.4. Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
- 10.4.5. Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.6. Infantile Spasm Therapeutics Market - UK
  - 10.4.6.1. UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.6.2. UK.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.6.3. UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.6.4. UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.6.5. UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.7. Infantile Spasm Therapeutics Market - France
  - 10.4.7.1. France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.7.2. France.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.7.3. France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.7.4. France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.7.5. France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.8. Infantile Spasm Therapeutics Market - Germany
  - 10.4.8.1. Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.8.2. Germany.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.8.3. Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.8.4. Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.8.5. Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.9. Infantile Spasm Therapeutics Market - Italy
  - 10.4.9.1. Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.9.2. Italy.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.9.3. Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.9.4. Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.9.5. Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.10. Infantile Spasm Therapeutics Market - Spain
  - 10.4.10.1. Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.10.2. Spain.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.10.3. Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.10.4. Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.10.5. Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.11. Infantile Spasm Therapeutics Market - Netherlands
  - 10.4.11.1. Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.11.2. Netherlands.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.11.3. Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.11.4. Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.11.5. Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.4.12. Infantile Spasm Therapeutics Market - Russia
  - 10.4.12.1. Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.4.12.2. Russia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.4.12.3. Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.4.12.4. Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.4.12.5. Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
10.5. Infantile Spasm Therapeutics Market - Asia Pacific
- 10.5.1. Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.6. Infantile Spasm Therapeutics Market - China
  - 10.5.6.1. China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.6.2. China.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.6.3. China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.6.4. China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.6.5. China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.7. Infantile Spasm Therapeutics Market - India
  - 10.5.7.1. India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.7.2. India.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.7.3. India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.7.4. India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.7.5. India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.8. Infantile Spasm Therapeutics Market - Japan
  - 10.5.8.1. Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.8.2. Japan.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.8.3. Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.8.4. Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.8.5. Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.9. Infantile Spasm Therapeutics Market - Malaysia
  - 10.5.9.1. Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.9.2. Malaysia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.9.3. Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.9.4. Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.9.5. Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.10. Infantile Spasm Therapeutics Market - Indonesia
  - 10.5.10.1. Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.10.2. Indonesia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.10.3. Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.10.4. Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.10.5. Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.5.11. Infantile Spasm Therapeutics Market - South Korea
  - 10.5.11.1. South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.5.11.2. South Korea.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.5.11.3. South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.5.11.4. South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.5.11.5. South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
10.6. Infantile Spasm Therapeutics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.6. Infantile Spasm Therapeutics Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.6.6.2. Saudi Arabia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.6.6.3. Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.6.6.4. Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.6.6.5. Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.7. Infantile Spasm Therapeutics Market - UAE
  - 10.6.7.1. UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.6.7.2. UAE.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.6.7.3. UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.6.7.4. UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.6.7.5. UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.8. Infantile Spasm Therapeutics Market - Israel
  - 10.6.8.1. Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.6.8.2. Israel.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.6.8.3. Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.6.8.4. Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.6.8.5. Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.6.9. Infantile Spasm Therapeutics Market - South Africa
  - 10.6.9.1. South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.6.9.2. South Africa.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.6.9.3. South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.6.9.4. South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.6.9.5. South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
10.7. Infantile Spasm Therapeutics Market - Latin America
- 10.7.1. Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
- 10.7.2. Latin America.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
- 10.7.3. Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
- 10.7.4. Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
- 10.7.5. Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.6. Infantile Spasm Therapeutics Market - Mexico
  - 10.7.6.1. Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.7.6.2. Mexico.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.7.6.3. Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.7.6.4. Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.7.6.5. Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.7. Infantile Spasm Therapeutics Market - Brazil
  - 10.7.7.1. Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.7.7.2. Brazil.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.7.7.3. Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.7.7.4. Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.7.7.5. Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
- 10.7.8. Infantile Spasm Therapeutics Market - Argentina
  - 10.7.8.1. Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  - 10.7.8.2. Argentina.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  - 10.7.8.3. Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  - 10.7.8.4. Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  - 10.7.8.5. Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Lundbeck
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Mallinckrodt Pharmaceuticals
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Catalyst Pharmaceuticals
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. GW Pharmaceuticals
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Retrophin
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Valerion Therapeutics
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Orphelia Pharma
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Insys Therapeutics
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Anavex Life Sciences Corp
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development

Product Code: PM3416

List of Tables

Table 1 Global Infantile Spasm Therapeutics Market, by Therapeutic Class, by Region, 2019-2032 (USD Million)
Table 2 Global Infantile Spasm Therapeutics Market, by Drug Type, by Region, 2019-2032 (USD Million)
Table 3 Global Infantile Spasm Therapeutics Market, by Dosage, by Region, 2019-2032 (USD Million)
Table 4 Global Infantile Spasm Therapeutics Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
Table 5 Global Infantile Spasm Therapeutics Market, by Route of Administration, by Region, 2019-2032 (USD Million)
Table 6 North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 7 North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 8 North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 9 North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 10 North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 11 U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 12 U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 13 U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 14 U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 15 U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 16 Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 17 Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 18 Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 19 Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 20 Canada: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 21 Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 22 Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 23 Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 24 Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 25 Europe: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 26 Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 27 Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 28 Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 29 Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 30 Germany: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 31 France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 32 France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 33 France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 34 France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 35 France: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 36 UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 37 UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 38 UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 39 UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 40 UK: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 41 Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 42 Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 43 Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 44 Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 45 Italy: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 46 Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 47 Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 48 Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 49 Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 50 Netherlands: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 51 Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 52 Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 53 Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 54 Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 55 Spain: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 56 Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 57 Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 58 Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 59 Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 60 Russia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 61 Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 62 Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 63 Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 64 Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 65 Asia Pacific: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 66 China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 67 China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 68 China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 69 China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 70 China: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 71 Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 72 Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 73 Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 74 Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 75 Japan: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 76 India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 77 India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 78 India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 79 India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 80 India: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 81 Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 82 Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 83 Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 84 Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 85 Indonesia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 86 Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 87 Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 88 Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 89 Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 90 Malaysia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 91 South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 92 South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 93 South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 94 South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 95 South Korea: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 96 Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 97 Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 98 Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 99 Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 100 Latin America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 101 Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 102 Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 103 Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 104 Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 105 Brazil: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 106 Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 107 Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 108 Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 109 Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 110 Mexico: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 111 Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 112 Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 113 Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 114 Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 115 Argentina: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 116 Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 117 Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 118 Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 119 Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 120 Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 121 UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 122 UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 123 UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 124 UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 125 UAE: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 126 Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 127 Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 128 Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 129 Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 130 Saudi Arabia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 131 South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 132 South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 133 South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 134 South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 135 South Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
Table 136 Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
Table 137 Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
Table 138 Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
Table 139 Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
Table 140 Israel: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Infantile Spasm Therapeutics Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Therapeutic Class
Figure 7. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2021 & 2030 (USD Million)
Figure 8. Market by Drug Type
Figure 9. Global Infantile Spasm Therapeutics Market, by Drug Type, 2021 & 2030 (USD Million)
Figure 10. Market by Dosage
Figure 11. Global Infantile Spasm Therapeutics Market, by Dosage, 2021 & 2030 (USD Million)
Figure 12. Market by Distribution Channel
Figure 13. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2021 & 2030 (USD Million)
Figure 14. Market by Route of Administration
Figure 15. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2021 & 2030 (USD Million)

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032

Description

Table of Contents

List of Tables

Infantile Spasm Therapeutics Market Report Highlights

Infantile Spasm Therapeutics Market, Therapeutic Class Outlook (Revenue - USD Million, 2019 - 2032)

Infantile Spasm Therapeutics Market, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

Infantile Spasm Therapeutics Market, Dosage Outlook (Revenue - USD Million, 2019 - 2032)

Infantile Spasm Therapeutics Market, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Infantile Spasm Therapeutics Market, Distribution Channel Outlook (Revenue - USD Million, 2019 -2032)

Infantile Spasm Therapeutics Market, Region Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Infantile Spasm Therapeutics Market Insights

5. Global Infantile Spasm Therapeutics Market, by Therapeutic Class

6. Global Infantile Spasm Therapeutics Market, by Drug Type

7. Global Infantile Spasm Therapeutics Market, by Dosage

8. Global Infantile Spasm Therapeutics Market, by Route of Administration

9. Global Infantile Spasm Therapeutics Market, by Distribution Channel

10. Global Infantile Spasm Therapeutics Market, by Geography

11. Competitive Landscape

12. Company Profiles

List of Tables

List of Figures